Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Beyond Pills: Designing a Winning Delivery Strategy for the New Era of Biologics

July 31, 2015 | by Nurry Hong, Managing Director; Sue St. Sure, Managing Director; and Max Cambras, Life Sciences Expert, Manager, of L.E.K. Consulting | Articles | Comments

With the rise of biologics, drug delivery presents new challenges as many companies are still taking a fragmented approach, resulting in delayed (or suboptimal) product launches and life cycle management. The problem is that it’s extremely difficult, if not impossible, to fix drug delivery challenges after the fact, so companies need a clear strategy in advance. Read more...

View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Receive $1.4M to Study Drug Candidates for Neurological Disorders, Other Diseases

July 31, 2015 9:51 am | by The Scripps Research Institute | News | Comments

The project involves studying what are known as RORs (retinoic acid receptor-related orphan receptors). Read more...


Amgen Hikes 2015 Forecast After 2Q Increase in Profit, Sales

July 31, 2015 9:39 am | by Linda A. Johnson, AP Business Writer | News | Comments

Amgen shares jumped in extended trading after the maker of osteoporosis drug Prolia easily beat Wall Street's second-quarter profit expectations and hiked its 2015 financial forecast. Read more...


Cipher Pharmaceuticals Announces Successful Completion of Second Phase 3 Study for Ozenoxacin

July 31, 2015 8:54 am | News | Comments

Company expects to submit Ozenoxacin for regulatory approval in Canada in the first quarter of 2016. Read more...


UN Ebola Mission Winds Down, WHO Takes Reins in West Africa

July 31, 2015 8:48 am | by Maria Cheng and Raphael Satter, Associated Press Medical Writer | News | Comments

The United Nations Mission for Ebola Emergency Response is officially winding down Friday. Read more...


EMA Grants Accelerated Assessment of Takeda's Ixazomib

July 31, 2015 8:41 am | News | Comments

The EMA awards an accelerated assessment to those medicines deemed to be of major public health interest and, in particular, therapeutic innovation. Read more...


Researchers Discover New Type of Mycovirus

July 31, 2015 8:40 am | by University of Hertfordshire | News | Comments

Virus infects the fungus Aspergillus fumigatus, which can cause the human disease aspergillosis. Read more...


Teva's $40.5B Allergan Acquisition Likely to Yield Substantial Returns

July 31, 2015 8:40 am | by Gianfranco Zeppetelli, Deals Analyst, GlobalData | Articles | Comments

Teva's bid for Allergan’s generics business illustrates that it has given up on its pursuit of rival Mylan NV. Read more...


'Cracking' Gluten Intolerance

July 31, 2015 8:39 am | by University of Alberta | News | Comments

Researchers may have found a way to help people with celiac disease enjoy the wide variety of foods they normally have to shun. Read more...


Health Care Spending to Accelerate, U.S. Report Says

July 30, 2015 1:25 pm | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

It's lasted six years. But now welcome relief from rising U.S. health care costs seems to be winding down. Read more...


Par Pharmaceutical Begins Shipment of Generic Megace ES

July 30, 2015 1:11 pm | News | Comments

Par’s launch of its authorized generic product follows a competitor’s introduction of the first generic version of Megace ES. Read more...


Roche Submits FDA Filing for Companion Diagnostic for NSCLC Drug Therapy

July 30, 2015 12:54 pm | News | Comments

Roche announced it has submitted the cobas EGFR Mutation Test v2 for Premarket Approval (PMA) to the U.S. Food and Drug Administration. Read more...


Identifying a Key Growth Factor in Cell Proliferation

July 30, 2015 12:35 pm | by MIT | News | Comments

Mitochondria are well known for their role as powerhouses in our cells, using respiration to release the energy in the food we eat and trapping that energy in the molecule adenosine triphosphate, or ATP. Read more...


Drug Firm AstraZeneca Reports Slide in Earnings

July 30, 2015 12:19 pm | by The Associated Press | News | Comments

Anglo-Swedish drug firm AstraZeneca said second-quarter net income fell 12 percent to $697 million as competition from generic drug companies reduced sales. Read more...


Mechanism Behind the Lack of Effectiveness of Certain Antagonist Drugs Discovered

July 29, 2015 11:05 am | by University of Barcelona | News | Comments

Researchers have published a study in the journal Proceedings of the National Academy of Sciences (PNAS) about the formation of G protein-coupled receptors (GPCRs) which allows understanding the unexpected behaviour of some antagonists that block physiological responses. Read more..


Mylan Gets European Clearance in Proposed Perrigo Takeover

July 29, 2015 11:00 am | News | Comments

Mylan NV said Wednesday that it received European regulatory approval to move forward with its proposed buyout of Perrigo Co., which has resisted repeated overtures. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.